Last reviewed · How we verify
NCT05496985
Chinese Validation of the Simplified Evaluation of CONsciousness Disorders（SECONDs）
NA trial testing Simplified Evaluation of CONsciousness Disorders (SECONDs) in Brain Diseases in 49 participants. Completed in 14 March 2022.
14 March 2022
Quick facts
| Lead sponsor | Hangzhou Normal University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 49 |
| Start date | 20 December 2021 |
| Primary completion | 14 March 2022 |
| Estimated completion | 14 March 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Simplified Evaluation of CONsciousness Disorders (SECONDs)
Conditions studied
- Brain Diseases — all drugs for Brain Diseases →
- Vegetative State — all drugs for Vegetative State →
- Unconsciousness — all drugs for Unconsciousness →
- Central Nervous System Diseases — all drugs for Central Nervous System Diseases →
Sponsor
Hangzhou Normal University
Who can join
Adults 18 to 85, any sex, with Brain Diseases or Vegetative State. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to translate the SECONDs from French into Chinese and assess the validity and reliability of the Chinese version of the SECONDs .
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05496985
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Simplified Evaluation of CONsciousness Disorders (SECONDs)
Trials testing the same drug.
- NCT07456020 — Assessment of Consciousness With CRS-R and SECONDs · recruiting
- NCT04687553 — Validation of the Chinese Version of the SECONDs · NA · completed
Other recruiting trials for Brain Diseases
Currently open trials in the same condition.
- NCT07185022 — Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion · NA · recruiting
- NCT07305948 — Evaluation of a New MRI Technique to Reduce Breathing-Related Artifacts in Brain Imaging · recruiting
- NCT07288385 — Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Uppe · NA · recruiting
- NCT07324330 — Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity · NA · recruiting
- NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
Other Hangzhou Normal University trials
Trials by the same sponsor.
- NCT06536985 — Effect of an Oral Frailty Measures Intervention Programs in Institutionalized Elders · NA · not yet recruiting
- NCT06519695 — Exercise Intervention for Pre-frail Elderly · NA · active not recruiting
- NCT06014476 — Psychological Symptoms and Burden in Caregivers of Patients With Disorders of Consciousness · completed
- NCT06770348 — Investigating the Localization of Consciousness Through Patients with Disorders of Consciousness: Anterior Vs. Posterior · completed
- NCT04687553 — Validation of the Chinese Version of the SECONDs · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05496985 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hangzhou Normal University
- Last refreshed: 11 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05496985.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing